In our study, we found that CXCL13 was specifically upregulated in tumor-infiltrated TCR135-positive CD4+ T cells, while ZNF683 was specifically upregulated in tumor-infiltrated TCR135-positive CD8+ T cells (Supplemental Figure 13). Here, CXCL13 is linked to neoplasm.